跳至主要内容
临床试验/NCT06956391
NCT06956391招募中2 期

Evaluation of Ultralow Dose PET Imaging for Detecting 18F-FDG Uptake

Akiva Mintz1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年5月12日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
Signal-to-Noise Ratio (SNR)

研究概览

简要总结

The goal of this clinical trial is to evaluate an investigational ultralow dose PET imaging technique for cancer detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold of the current clinical standard? Participants will be injected with a radioactive tracer called 18F-FDG and be imaged on a new type of high-sensitivity PET scanner for up to 3 hours.

详细描述

This research study aims to evaluate an investigational ultralow dose PET imaging technique for cancer detection and monitoring. "Investigational" means that the procedure or drug being studied is not yet approved by the FDA for the specific use being tested in this research. The PET imaging technique used in this study is considered investigational because it is being tested at an ultralow radiation dose that has not yet been approved for clinical use. The radiotracer, 18F-FDG, is FDA-approved for detecting cancer at standard doses.

18F-FDG is often found to be taken up at higher levels in cancer. In this study, investigators will use a very small amount of this tracer (less than 1/20th of the standard dose) along with advanced PET imaging technology to see if it is possible to create clear images while using much less radiation. This study aims to develop a safer imaging technique that could potentially be used more frequently for screening and monitoring cancer.

Investigators will enroll individuals with and without cancer to evaluate how ultralow dose PET imaging detects 18F-FDG uptake in different types of tissue.

Approximately 200 people will be enrolled in this study at the Nuclear Imaging Institute.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years.
  • Ability to provide informed consent and comply with study procedures.
  • For female participants:
  • Must not be pregnant or breastfeeding.
  • Negative pregnancy test required for women of childbearing potential.

排除标准

  • Participants who have exceeded NRC regulation for annual radiation exposure from prior research-related scans, including this study (50 mSv total).
  • More than four prior enrollments in this study.
  • Participants with severe claustrophobia, chronic pain, or musculoskeletal conditions that prevent completion of the PET scan
  • Medication & Prior Treatment Exclusions
  • Pregnant or breastfeeding individuals (negative pregnancy test required)
  • Inability to provide informed consent
  • Any condition that, in the investigator's judgment, may compromise participant safety or study integrity.

研究组 & 干预措施

Ultralow Dose 18F-FDG Imaging Group

Experimental

干预措施: 18F-FDG (Drug)

结局指标

主要结局

Signal-to-Noise Ratio (SNR)

时间窗: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.

Measurement of signal-to-noise ratio for image quality assessment across different scan durations, reconstruction techniques, and AI-enhanced image reconstructions. Unit of Measure: SNR (unitless, numeric ratio)

Contrast-to-Noise Ratio (CNR)

时间窗: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.

Measurement of contrast-to-noise ratio for image quality assessment across different scan durations, reconstruction techniques, and AI-enhanced image reconstructions. Unit of Measure: CNR (unitless, numeric ratio)

Coefficient of Variation (COV)

时间窗: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.

Measurement of the coefficient of variation in selected regions for evaluating image consistency across different scan durations, reconstruction techniques, and AI-enhanced image reconstructions. Unit of Measure: Percentage (%)

Spatial Resolution (Full Width at Half Maximum - FWHM)

时间窗: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.

Assessment of spatial resolution using full width at half maximum (FWHM) across different scan durations, reconstruction techniques, and AI-enhanced image reconstructions. Unit of Measure: Millimeters (mm)

Target-to-Background Ratio (TBR)

时间窗: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.

Assessment of target-to-background ratio for evaluating PSMA-expressing tissue contrast across different scan durations, reconstruction techniques, and AI-enhanced image reconstructions. Unit of Measure: Ratio (unitless numeric ratio)

Qualitative Image Quality Score (Likert Scale)

时间窗: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.

Independent qualitative evaluation of overall image quality, lesion detectability, image noise, and artifacts by nuclear medicine physicians, assessed using a 5-point Likert scale. Unit of Measure: Score on Likert Scale (1-5; 1 = worst, 5 = best)

Inter-reader Agreement (Weighted Kappa Statistics)

时间窗: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.

Measurement of agreement among readers evaluating qualitative image quality scores, analyzed using weighted kappa statistics. Unit of Measure: Weighted kappa statistic (numeric value ranging from 0 to 1, 0 = no agreement, 1 = perfect agreement)

次要结局

未报告次要终点

研究者

发起方
Akiva Mintz
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Akiva Mintz

Executive Director

Nuclear Imaging Institute

研究点 (1)

Loading locations...

相似试验